Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study.
暂无分享,去创建一个
Carles Falcon | Pilar Salgado-Pineda | Olivier Blin | O. Blin | C. Falcón | P. Salgado-Pineda | P. Delaveau | Pauline Delaveau
[1] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[2] M. Rudin,et al. From anatomy to the target: Contributions of magnetic resonance imaging to preclinical pharmaceutical research , 2001, The Anatomical record.
[3] T. Reese,et al. In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives , 1999, NMR in biomedicine.
[4] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[5] Karl J. Friston,et al. Voxel-based morphometry , 2007 .
[6] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[7] Karl J. Friston,et al. Cerebral Asymmetry and the Effects of Sex and Handedness on Brain Structure: A Voxel-Based Morphometric Analysis of 465 Normal Adult Human Brains , 2001, NeuroImage.
[8] Mark Preece,et al. Detection of pharmacologically mediated changes in cerebral activity by functional magnetic resonance imaging: the effects of sulpiride in the brain of the anaesthetised rat , 2001, Brain Research.
[9] P. Riederer,et al. The role of iron in senescence of dopaminergic neurons in Parkinson's disease. , 1993, Journal of neural transmission. Supplementum.
[10] K. Jellinger,et al. The Role of Iron in Neurodegeneration , 1999, Drugs & aging.
[11] Y Yonekura,et al. An introduction to PET and SPECT neuroreceptor quantification models. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] Markus Rudin,et al. Magnetic resonance imaging in drug discovery: lessons from disease areas. , 2004, Drug discovery today.
[13] D. Tank,et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[14] O. Rascol,et al. L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. , 1999, Clinical neuropharmacology.
[15] C. PedroChaná,et al. Comparación farmacocinética de Sinemet â y Grifoparkin â (levodopa/carbidopa 250/25 mg) en pacientes con enfermedad de Parkinson avanzada: un estudio con dosis única , 2003 .
[16] M. James,et al. Pharmacological magnetic resonance imaging: a new application for functional MRI. , 2000, Trends in pharmacological sciences.
[17] O. Blin,et al. Levodopa-induced Drowsiness in Healthy Volunteers: Results of a Choice Reaction Time Test Combined with a Subjective Evaluation of Sedation , 2001, Clinical neuropharmacology.
[18] E. Bullmore,et al. Human pharmacological MRI. , 2004, Trends in pharmacological sciences.
[19] J. Fozard,et al. Techniques: magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs. , 2003, Trends in pharmacological sciences.